1887

Abstract

Porcine circovirus type 2 (PCV2) is a primary causative agent of postweaningmultisystemic wasting syndrome (PMWS), which has a significant economic impact on the swine industry. The capsid protein (Cap) encoded by ORF2 of the viral genome has been used effectively as a vaccine against PCV2 infection. The Cap protein can spontaneously assemble into virus-like particles (VLPs) that are safe and highly immunogenic for vaccine applications. Several expression systems, including bacteria, yeast and insect cells, have been utilized to produce PCV2 VLPs. However, in some cases, the recombinant Cap (rCap) proteins produced in bacteria and yeast do not assemble spontaneously. In this study, we expressed rCap protein using a silkworm–baculovirus expression vector system (silkworm–BEVS) for mass production of PCV2 VLPs and established a simple three-step protocol for its purification from pupae: extraction by detergent, ammonium sulfate precipitation and anion exchange column chromatography. Size-exclusion chromatography (SEC) analysis and transmission electron microscope (TEM) observation showed that purified rCap proteins formed VLPs with a similar morphology to that of the original virus. Furthermore, the VLPs produced in silkworms were capable of inducing neutralizing antibodies against PCV2 in mice. Our results demonstrated that the silkworm system is a powerful tool for the production of PCV2 VLPs and will be useful for the development of a reliable and cost-effective PCV2 vaccine.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001087
2018-07-01
2020-01-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/99/7/917.html?itemId=/content/journal/jgv/10.1099/jgv.0.001087&mimeType=html&fmt=ahah

References

  1. Ellis J, Hassard L, Clark E, Harding J, Allan G et al. Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome. Can Vet J 1998;39:44–51[PubMed]
    [Google Scholar]
  2. Allan GM, Ellis JA. Porcine circoviruses: a review. J Vet Diagn Invest 2000;12:3–14 [CrossRef][PubMed]
    [Google Scholar]
  3. Allan GM, Kennedy S, McNeilly F, Foster JC, Ellis JA et al. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J Comp Pathol 1999;121:1–11 [CrossRef][PubMed]
    [Google Scholar]
  4. Harms PA, Sorden SD, Halbur PG, Bolin SR, Lager KM et al. Experimental reproduction of severe disease in CD/CD pigs concurrently infected with type 2 porcine circovirus and porcine reproductive and respiratory syndrome virus. Vet Pathol 2001;38:528–539 [CrossRef][PubMed]
    [Google Scholar]
  5. Crowther RA, Berriman JA, Curran WL, Allan GM, Todd D. Comparison of the structures of three circoviruses: chicken anemia virus, porcine circovirus type 2, and beak and feather disease virus. J Virol 2003;77:13036–13041 [CrossRef][PubMed]
    [Google Scholar]
  6. Nawagitgul P, Morozov I, Bolin SR, Harms PA, Sorden SD et al. Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J Gen Virol 2000;81:2281–2287 [CrossRef][PubMed]
    [Google Scholar]
  7. López-Sagaseta J, Malito E, Rappuoli R, Bottomley MJ. Self-assembling protein nanoparticles in the design of vaccines. Comput Struct Biotechnol J 2016;14:58–68 [CrossRef][PubMed]
    [Google Scholar]
  8. Grgacic EV, Anderson DA. Virus-like particles: passport to immune recognition. Methods 2006;40:60–65 [CrossRef][PubMed]
    [Google Scholar]
  9. Clark MR, Massenburg D, Zhang M, Siemasko K. Molecular mechanisms of B cell antigen receptor trafficking. Ann N Y Acad Sci 2003;987:26–37 [CrossRef][PubMed]
    [Google Scholar]
  10. Monroe JG, Cambier JC. B cell activation. II. Receptor cross-linking by thymus-independent and thymus-dependent antigens induces a rapid decrease in the plasma membrane potential of antigen-binding B lymphocytes. J Immunol 1983;131:2641–2644[PubMed]
    [Google Scholar]
  11. Zhang T, Xu Y, Qiao L, Wang Y, Wu X et al. Trivalent human papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types. Vaccine 2010;28:3479–3487 [CrossRef][PubMed]
    [Google Scholar]
  12. Murata K, Lechmann M, Qiao M, Gunji T, Alter HJ et al. Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection. Proc Natl Acad Sci USA 2003;100:6753–6758 [CrossRef][PubMed]
    [Google Scholar]
  13. Akahata W, Yang ZY, Andersen H, Sun S, Holdaway HA et al. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med 2010;16:334–338 [CrossRef][PubMed]
    [Google Scholar]
  14. Breitburd F, Kirnbauer R, Hubbert NL, Nonnenmacher B, Trin-Dinh-Desmarquet C et al. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol 1995;69:3959–3963[PubMed]
    [Google Scholar]
  15. Trible BR, Suddith AW, Kerrigan MA, Cino-Ozuna AG, Hesse RA et al. Recognition of the different structural forms of the capsid protein determines the outcome following infection with porcine circovirus type 2. J Virol 2012;86:13508–13514 [CrossRef][PubMed]
    [Google Scholar]
  16. Wu PC, Lin WL, Wu CM, Chi JN, Chien MS et al. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development. Appl Microbiol Biotechnol 2012;95:1501–1507 [CrossRef][PubMed]
    [Google Scholar]
  17. Nainys J, Lasickiene R, Petraityte-Burneikiene R, Dabrisius J, Lelesius R et al. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies. BMC Biotechnol 2014;14:100 [CrossRef][PubMed]
    [Google Scholar]
  18. Liu Q, Tikoo SK, Babiuk LA. Nuclear localization of the ORF2 protein encoded by porcine circovirus type 2. Virology 2001;285:91–99 [CrossRef][PubMed]
    [Google Scholar]
  19. Zhou JY, Shang SB, Gong H, Chen QX, Wu JX et al. In vitro expression, monoclonal antibody and bioactivity for capsid protein of porcine circovirus type II without nuclear localization signal. J Biotechnol 2005;118:201–211 [CrossRef][PubMed]
    [Google Scholar]
  20. Liu Q, Willson P, Attoh-Poku S, Babiuk LA. Bacterial expression of an immunologically reactive PCV2 ORF2 fusion protein. Protein Expr Purif 2001;21:115–120 [CrossRef][PubMed]
    [Google Scholar]
  21. Yin S, Sun S, Yang S, Shang Y, Cai X et al. Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli. Virol J 2010;7:166 [CrossRef][PubMed]
    [Google Scholar]
  22. Marcekova Z, Psikal I, Kosinova E, Benada O, Sebo P et al. Heterologous expression of full-length capsid protein of porcine circovirus 2 in Escherichia coli and its potential use for detection of antibodies. J Virol Methods 2009;162:133–141 [CrossRef][PubMed]
    [Google Scholar]
  23. Tu Y, Wang Y, Wang G, Wu J, Liu Y et al. High-level expression and immunogenicity of a porcine circovirus type 2 capsid protein through codon optimization in Pichia pastoris. Appl Microbiol Biotechnol 2013;97:2867–2875 [CrossRef][PubMed]
    [Google Scholar]
  24. Bucarey SA, Noriega J, Reyes P, Tapia C, Sáenz L et al. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts. Vaccine 2009;27:5781–5790 [CrossRef][PubMed]
    [Google Scholar]
  25. Kato T, Kajikawa M, Maenaka K, Park EY. Silkworm expression system as a platform technology in life science. Appl Microbiol Biotechnol 2010;85:459–470 [CrossRef][PubMed]
    [Google Scholar]
  26. Maesaki R, Satoh R, Taoka M, Kanaba T, Asano T et al. Efficient and cost effective production of active-form human PKB using silkworm larvae. Sci Rep 2014;4:6016 [CrossRef][PubMed]
    [Google Scholar]
  27. Masuda A, Xu J, Mitsudome T, Nagata Y, Morokuma D et al. Mass production of an active peptide-N-glycosidase F using silkworm-baculovirus expression system. Mol Biotechnol 2015;57:735–745 [CrossRef][PubMed]
    [Google Scholar]
  28. Hino M, Kawanami T, Xu J, Morokuma D, Hirata K et al. High-level expression and purification of biologically active human IL-2 using silkworm-baculovirus expression vector system. J Asia Pac Entomol 2016;19:313–317 [CrossRef]
    [Google Scholar]
  29. Yamashita M, Xu J, Morokuma D, Hirata K, Hino M et al. Characterization of recombinant Thermococcus kodakaraensis (KOD) DNA polymerases produced using silkworm-baculovirus expression vector system. Mol Biotechnol 2017;59:221–233 [CrossRef][PubMed]
    [Google Scholar]
  30. Peixoto C, Sousa MF, Silva AC, Carrondo MJ, Alves PM. Downstream processing of triple layered rotavirus like particles. J Biotechnol 2007;127:452–461 [CrossRef][PubMed]
    [Google Scholar]
  31. Tojo S, Nagata M, Kobayashi M. Storage proteins in the silkworm, Bombyx mori. Insect Biochemistry 1980;10:289–303 [CrossRef]
    [Google Scholar]
  32. Kim EJ, Park HJ, Park TH. Inhibition of apoptosis by recombinant 30K protein originating from silkworm hemolymph. Biochem Biophys Res Commun 2003;308:523–528 [CrossRef][PubMed]
    [Google Scholar]
  33. Hou Q, Hou S, Chen Q, Jia H, Xin T et al. Nuclear localization signal regulates porcine circovirus type 2 capsid protein nuclear export through phosphorylation. Virus Res 2018;246:12–22 [CrossRef][PubMed]
    [Google Scholar]
  34. Zaveckas M, Snipaitis S, Pesliakas H, Nainys J, Gedvilaite A. Purification of recombinant virus-like particles of porcine circovirus type 2 capsid protein using ion-exchange monolith chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2015;991:21–28 [CrossRef][PubMed]
    [Google Scholar]
  35. Trible BR, Kerrigan M, Crossland N, Potter M, Faaberg K et al. Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease. Clin Vaccine Immunol 2011;18:749–757 [CrossRef][PubMed]
    [Google Scholar]
  36. Wu PC, Chen TY, Chi JN, Chien MS, Huang C. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli. J Biotechnol 2016;220:78–85 [CrossRef][PubMed]
    [Google Scholar]
  37. Watanabe S, Iizuka T, Hatama S, Kanno T, Mase M et al. Production of highly immunogenic virus-like particles of bovine papillomavirus type 6 in silkworm pupae. Vaccine 2017;35:5878–5882 [CrossRef][PubMed]
    [Google Scholar]
  38. Matsuda S, Nerome R, Maegawa K, Kotaki A, Sugita S et al. Development of a Japanese encephalitis virus-like particle vaccine in silkworms using codon-optimised prM and envelope genes. Heliyon 2017;3:e00286 [CrossRef][PubMed]
    [Google Scholar]
  39. Nerome K, Sugita S, Kuroda K, Hirose T, Matsuda S et al. The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae. Vaccine 2015;33:117–125 [CrossRef][PubMed]
    [Google Scholar]
  40. Liu LJ, Suzuki T, Tsunemitsu H, Kataoka M, Ngata N et al. Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus. Arch Virol 2008;153:2291–2295 [CrossRef][PubMed]
    [Google Scholar]
  41. Liu Y, Zhang Y, Yao L, Hao H, Fu X et al. Enhanced production of porcine circovirus type 2 (PCV2) virus-like particles in Sf9 cells by translational enhancers. Biotechnol Lett 2015;37:1765–1771 [CrossRef][PubMed]
    [Google Scholar]
  42. Ono C, Nakatsukasa T, Nishijima Y, Asano S, Sahara K et al. Construction of the BmNPV T3 bacmid system and its application to the functional analysis of BmNPV he65. J Insect Biotechnol Sericology 2007;76:161–167
    [Google Scholar]
  43. Park EY, Abe T, Kato T. Improved expression of fusion protein using a cysteine- protease- and chitinase-deficient Bombyx mori (silkworm) multiple nucleopolyhedrovirus bacmid in silkworm larvae. Biotechnol Appl Biochem 2008;49:135–140 [CrossRef][PubMed]
    [Google Scholar]
  44. Guo XY, Guo TQ, Wang SP, Wang JY, Lu CD. Silk gland specific secretory expression of egfp gene in silkworm Bombyx mori with rAcMNPV system. Arch Virol 2005;150:1151–1160 [CrossRef][PubMed]
    [Google Scholar]
  45. Hitchman RB, Possee RD, Crombie AT, Chambers A, Ho K et al. Genetic modification of a baculovirus vector for increased expression in insect cells. Cell Biol Toxicol 2010;26:57–68 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001087
Loading
/content/journal/jgv/10.1099/jgv.0.001087
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error